BetaShares Global Shares Ex US ETF is an International shares ETF from BetaShares — 869 holdings. 24% of its money is in financials. Its two largest holdings, ASML HOLDING NV and ROCHE HOLDING AG, make up 4% of the fund. It charges 0.14% a year.
- TypeInternational shares
- IssuerBetaShares
- Cost0.14% a year
- Holdings869
- Top sectorFinancials 24%
- DistributionsHistory
- Top 2 holdings4%
the last 3 months
$10,000 in EXUS fell to $9,748.
No payout is counted in this period.
−2.52% by price
▲ ①What added the most
One company added the most: AstraZeneca
AstraZeneca added +$10 on every $10,000. Its share price rose 9.9% over the period, in its own currency. On average $104 of every $10,000 in EXUS was in AstraZeneca.
What moved it
▼ ②15 Oct · What took the most
One sector took the most: Information Technology
Information Technology took $187 on every $10,000. On average $993 of every $10,000 in EXUS was in it. The biggest part: ASML Holding, −$38.
◆ ③29 Oct · The rebalance
EXUS changed what it holds
Between its holdings lists of 29 Sep and 29 Oct, EXUS sold out of 2.
What it traded
Of every $10,000 in the fund
- Telecom ItaliaSold out−$5
- ManulifeBought more+$4
- NatWestBought more+$4
- CIBCBought more+$4
- SchrodersSold out−$3
- OCBCBought more+$3
- Start
- $10,000
- End
- $9,748
- High
- $10,166
- Low
- $9,732
High and low were 4% apart.
How it adds up, on $10,000
What you own
Of every $10,000 in EXUS
- ASML Holding$263
- HSBC$135
- Roche (ROP)$132
- The other 796$9,470
The news · estimated
What the news did
Results above what was expected added +$64; results below what was expected took $62 on $10,000.
Other news
Where they are
The companies by country
On $10,000 at the start
Compare
Funds like EXUS
- IVEiShares MSCI EAFE ETF85% of its country mix matchesCompare with EXUS
- VEUVanguard All-World ex-US Shares Index ETF63% of its country mix matchesCompare with EXUS
- VEQVanguard FTSE Europe Shares ETF57% of its country mix matchesCompare with EXUS
- IEUiShares Europe ETF57% of its country mix matchesCompare with EXUS
- Compare EXUS with any fund →